An open-label, single-dose, randomized, 4-period, crossover, bioequivalence study of clinical and commercial formulations of bazedoxifene/conjugated estrogens in healthy postmenopausal women
Phase of Trial: Phase I
Latest Information Update: 10 Dec 2007
At a glance
- Drugs Conjugated estrogens/bazedoxifene (Primary)
- Indications Menopausal syndrome
- Focus Pharmacokinetics
- Sponsors Pfizer
- 10 Dec 2007 Status changed from in progress to completed.
- 15 Nov 2007 New trial record.